Clinical Trial

Persistence of Oral DNA Adducts in Smokers and Vapers

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
No longer funded and not moving forward
Summary
This study aims to better understand what damage caused to oral cells from smoking and vaping might be important in the formation of oral cancers. We will compare levels of DNA damage between those asked to stop smoking or vaping to those who continue to smoke or vape and those who never use tobacco or nicotine products. The goal is to identify damage that is found at higher levels or remains in the oral cells longer because they might be more important in causing cancer than other types of damage.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-13; most recent amendment 2026-02-10.
Status change: Not Yet Recruiting → Withdrawn 2026-02-10
Trial Details
NCT Number NCT06983392
Lead Sponsor University of Minnesota
Conditions Smokers, Vaping, Healthy Volunteers
Start Date 2026-03-01
Primary Completion 2029-07-30 (estimated)
Study Completion 2030-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-13